Shanghai Biotechnology Corporation (formerly ShanghaiBio in China), a CRO subsidiary of Shanghai Biochip Co., Ltd. / National Engineering Center for Biochip at Shanghai, owns biotechnology service platforms including Microarray, Next Generation Sequencing, Biomarkers, Molecular Pathology, Bioinformatics/Biostatistics and other verification service platforms. Our services include gene expression profiling, genotyping, whole genome sequencing, whole exome capture sequencing, comparative genomics hybridization (CGH), DNA methylation, miRNA profiling, biomarker screening and validation, bioinformatics analysis and other technical services. We have provided the services for more than 20 multinational pharmaceutical companies (including the top ten pharmaceutical companies) and more than 1800 research institutions. SBC has completed more than 8000 projects so far. Our clients have published more than 400 papers that are collected by SCI (average IF 5.0). In China, SBC is the first service provider certified by Affymetrix, the first microarray service provider certified by Agilent, Illumina Certified Service Provider (CSPro) and SOLID Demo Lab certified by ABI. Its service quality has been recognized by its partners with awards such as "Best Service Provider by Agilent", “Best Service Provider of Affymetrix" and “Novartis Supplier Award 2012”. The clinic testing laboratory at SBC is a certified clinical lab and certified PCR lab that provides services for target therapy, early diagnostics, predictive medicine and companion diagnostics. We detect biomarkers that may be associated with diseases, including single nucleotide polymorphism (SNP), gene mutations, deletions, rearrangements, insertions and others, for the fields of oncology, pharmacogenomics and genetic disease screening, etc. For detail about our service, please look at SBC’s overview and website at http://www.shanghaibiotech.com/eng/ or contact us at global_market@shbiochip.com.